Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(6)
Published: June 1, 2023
Abstract
Accumulating
evidence
shows
that
SARS‐CoV‐2
can
potentially
trigger
autoimmune
processes,
which
be
responsible
for
the
long‐term
consequences
of
COVID‐19.
Therefore,
this
paper
aims
to
review
autoantibodies
reported
in
COVID‐19
convalescents.
Six
main
groups
were
distinguished:
(i)
against
components
immune
system,
(ii)
cardiovascular
(iii)
thyroid
autoantibodies,
(iv)
specific
rheumatoid
diseases,
(v)
antibodies
G‐protein
coupled
receptors,
and
(vi)
other
autoantibodies.
The
reviewed
here
clearly
highlights
infection
may
induce
humoral
responses.
However,
available
studies
share
number
limitations,
such
as:
(1)
sole
presence
does
not
necessarily
implicate
clinically‐relevant
risks,
(2)
functional
investigations
rarely
performed
it
is
often
unknown
whether
observed
are
pathogenic,
(3)
control
seroprevalence,
healthy,
noninfected
individuals
was
reported;
thus
sometimes
detected
result
or
accidental
post‐COVID‐19
detection,
(4)
correlated
with
symptoms
syndrome,
(5)
size
studied
small,
(6)
focused
predominantly
on
adult
populations,
(7)
age‐
sex‐related
differences
seroprevalence
explored,
(8)
genetic
predispositions
involved
generation
during
infections
investigated,
(9)
reactions
following
variants
vary
clinical
course
remain
unexplored.
Further
longitudinal
advocated
assess
link
between
identified
particular
outcomes
Deutsches Ärzteblatt international,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Jan. 10, 2023
As
defined
by
the
WHO,
term
post-COVID
syndrome
(PCS)
embraces
a
group
of
symptoms
that
can
occur
following
acute
phase
SARS-CoV-2
infection
and
as
consequence
thereof.
PCS
is
found
mainly
in
adults,
less
frequently
children
adolescents.
It
develop
both
patients
who
initially
had
only
mild
or
none
at
all
those
severe
course
coronavirus
disease
2019
(COVID-19).The
data
presented
here
were
derived
from
systematic
literature
review.PCS
occurs
up
to
15%
unvaccinated
adults
infected
with
SARS-CoV-2.
The
prevalence
has
decreased
most
recent
pandemic
lower
after
vaccination.
pathogenesis
not
yet
been
fully
elucidated.
Virustriggered
inflammation,
autoimmunity,
endothelial
damage
(to
blood
vessels),
persistence
virus
are
thought
be
causative.
Owing
broad
viral
tropism,
different
organs
involved
vary.
To
date,
there
hardly
any
evidence-based
recommendations
for
definitive
diagnosis
its
treatment.The
gaps
our
knowledge
mean
better
documentation
necessary
compile
on
which
early
detection,
diagnosis,
treatment
based.
ensure
best
possible
care
PCS,
regional
centers
networks
embracing
existing
structures
healthcare
system
sectors
providers
should
set
structured
algorithms
established.
Given
sometimes
serious
consequences
affected,
it
seems
advisable
keep
number
infections
low
protective
measures
tailored
prevailing
situation.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 4, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
SARS-CoV-2
has
been
defined
as
the
greatest
global
health
and
socioeconomic
crisis
of
modern
times.
While
most
people
recover
after
being
infected
with
virus,
a
significant
proportion
them
continue
to
experience
issues
weeks,
months
even
years
acute
infection
SARS-CoV-2.
This
persistence
clinical
symptoms
in
individuals
for
at
least
three
onset
or
emergence
new
lasting
more
than
two
months,
without
any
other
explanation
alternative
diagnosis
have
named
long
COVID,
long-haul
post-COVID-19
conditions,
chronic
post-acute
sequelae
(PASC).
Long
COVID
characterized
constellation
disorders
that
vary
widely
their
manifestations.
Further,
mechanisms
underlying
are
not
fully
understood,
which
hamper
efficient
treatment
options.
review
describes
predictors
common
related
COVID's
effects
on
central
peripheral
nervous
system
organs
tissues.
Furthermore,
transcriptional
markers,
molecular
signaling
pathways
risk
factors
such
sex,
age,
pre-existing
condition,
hospitalization
during
phase
COVID-19,
vaccination,
lifestyle
presented.
Finally,
recommendations
patient
rehabilitation
management,
well
therapeutical
approaches
discussed.
Understanding
complexity
this
disease,
its
across
multiple
organ
systems
overlapping
pathologies
possible
paramount
developing
diagnostic
tools
treatments.
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Abstract
Long
COVID
(also
known
as
post-acute
sequelae
of
SARS-CoV-2
infection
[PASC]
or
post-COVID
syndrome)
is
characterized
by
persistent
symptoms
that
extend
beyond
the
acute
phase
infection,
affecting
approximately
10%
to
over
30%
those
infected.
It
presents
a
significant
clinical
challenge,
notably
due
pronounced
neurocognitive
such
brain
fog.
The
mechanisms
underlying
these
effects
are
multifactorial,
with
mounting
evidence
pointing
central
role
cerebromicrovascular
dysfunction.
This
review
investigates
key
pathophysiological
contributing
cerebrovascular
dysfunction
in
long
and
their
impacts
on
health.
We
discuss
how
endothelial
tropism
direct
vascular
trigger
dysfunction,
impaired
neurovascular
coupling,
blood–brain
barrier
disruption,
resulting
compromised
cerebral
perfusion.
Furthermore,
appears
induce
mitochondrial
enhancing
oxidative
stress
inflammation
within
cells.
Autoantibody
formation
following
also
potentially
exacerbates
injury,
chronic
ongoing
compromise.
These
factors
collectively
contribute
emergence
white
matter
hyperintensities,
promote
amyloid
pathology,
may
accelerate
neurodegenerative
processes,
including
Alzheimer’s
disease.
emphasizes
critical
advanced
imaging
techniques
assessing
health
need
for
targeted
interventions
address
complications.
A
deeper
understanding
essential
advance
treatments
mitigate
its
long-term
consequences.
American Journal of Hematology,
Journal Year:
2022,
Volume and Issue:
97(7), P. 915 - 923
Published: April 28, 2022
Abstract
Sustained
hypercoagulability
and
endotheliopathy
are
present
in
convalescent
COVID‐19
patients
for
up
to
4
months
from
recovery.
The
hemostatic,
endothelial,
inflammatory
profiles
of
39
recovered
were
evaluated
16
after
recovery
COVID‐19.
These
values
compared
with
a
control
group
healthy
volunteers
(
n
=
124).
(71.8%
males,
median
age
43
years)
reviewed
at
mean
12.7
±
3.6
following
One
patient
without
cardiovascular
risk
factors
had
post
acute
ischaemic
limb.
Elevated
D‐dimer
Factor
VIII
levels
above
normal
ranges
noted
17.9%
(7/39)
48.7%
(19/39)
respectively,
higher
0.34
FEU
μg/mL
(IQR
0.28,
0.46)
p
<
.001)
150%
171,
203)
.004),
versus
controls.
Thrombin
generation
(Thromboscreen)
showed
endogenous
thrombin
potential
(ETP)
1352
nM*min
1152,
1490)
.002)
peak
height
221.4
nM
170.2,
280.4)
0.01)
delayed
lag
time
2.4
min
(1.42–2.97)
0.0002)
Raised
vWF:Ag
ICAM‐1
observed
7.7%
(3/39)
VWF:Ag
117%
86,
154)
0.02)
54.1
ng/mL
43.8,
64.1)
.004)
than
IL‐6
was
be
raised
35.9%
(14/39)
patients,
1.5
pg/mL
0.6,
3.0)
0.004)
Subgroup
analysis
stratifying
by
severity
vaccination
preceding
SARS‐CoV‐2
infection
did
not
show
statistically
significant
differences.
Hypercoagulability,
endothelial
dysfunction,
inflammation
still
detectable
some
approximately
1
year
Angiogenesis,
Journal Year:
2022,
Volume and Issue:
26(1), P. 53 - 61
Published: Aug. 11, 2022
Abstract
Background
Recent
studies
have
highlighted
Coronavirus
disease
2019
(COVID-19)
as
a
multisystemic
vascular
disease.
Up
to
60%
of
the
patients
suffer
from
long-term
sequelae
and
persistent
symptoms
even
6
months
after
initial
infection.
Methods
This
prospective,
observational
study
included
58
participants,
27
whom
were
long
COVID
with
>
12
weeks
recovery
PCR-confirmed
SARS-CoV-2
Fifteen
healthy
volunteers
historical
cohort
critically
ill
COVID-19
(
n
=
16)
served
controls.
All
participants
underwent
sublingual
videomicroscopy
using
sidestream
dark
field
imaging.
A
newly
developed
version
Glycocheck™
software
was
used
quantify
density,
perfused
boundary
region
(PBR-an
inverse
variable
endothelial
glycocalyx
dimensions),
red
blood
cell
velocity
(VRBC)
microvascular
health
score
(MVHS™)
in
microvessels
diameters
4–25
µm.
Measurements
main
results
Although
dimensions
comparable
those
controls,
µm-precise
analysis
showed
significant
decrease
that
exclusively
affected
very
small
capillaries
(D5:
−
45.16%;
D6:
35.60%;
D7:
22.79%).
Plotting
VRBC
feed
vessels
number
did
not
respond
adequately
local
variations
tissue
metabolic
demand.
MVHS
markedly
reduced
(healthy
3.87
vs.
2.72
points;
p
0.002).
Conclusions
Our
current
data
strongly
suggest
leaves
capillary
rarefication
18
Whether,
what
extent,
when
observed
damage
might
be
reversible
remains
unclear.
Medicina,
Journal Year:
2022,
Volume and Issue:
58(3), P. 419 - 419
Published: March 12, 2022
Dyspnea,
shortness
of
breath,
and
chest
pain
are
frequent
symptoms
post-COVID
syndrome
(PCS).
These
unrelated
to
organ
damage
in
most
patients
after
mild
acute
COVID
infection.
Hyperventilation
has
been
identified
as
a
cause
exercise-induced
dyspnea
PCS.
Since
there
is
broad
overlap
symptomatology
with
myalgic
encephalomyelitis/chronic
fatigue
(ME/CFS),
causes
for
potential
consequences
can
be
deduced
by
stringent
application
assumptions
made
ME/CFS
our
recent
review
papers.
One
the
first
stimuli
respiration
exercise
caused
metabolic
feedback
via
skeletal
muscle
afferents.
PCS,
which
occurs
early
on
during
exercise,
arise
from
combined
disturbance
poor
energetic
situation
autonomic
dysfunction
(overshooting
respiratory
response),
both
found
ME/CFS.
The
exaggerated
response
aggravating
does
not
only
limit
ability
but
further
impairs
muscular
situation:
one
buffering
mechanisms
alkalosis
proton
shift
intracellular
extracellular
space
sodium–proton-exchanger
subtype
1
(NHE1),
thereby
loading
cells
sodium.
This
adds
two
other
sodium
already
operative,
namely
glycolytic
metabolism
(intracellular
acidosis)
impaired
Na+/K+ATPase
activity.
High
unfavorable
effects
mitochondrial
calcium
sodium–calcium-exchangers
(NCX).
Mitochondrial
overload
high
reversing
transport
mode
NCX
import
key
driver
chronification.
Prevention
hyperventilation
therapeutic
keeping
below
threshold
where
occurs.
Biochemical Journal,
Journal Year:
2022,
Volume and Issue:
479(16), P. 1653 - 1708
Published: Aug. 31, 2022
Ischaemia-reperfusion
(I-R)
injury,
initiated
via
bursts
of
reactive
oxygen
species
produced
during
the
reoxygenation
phase
following
hypoxia,
is
well
known
in
a
variety
acute
circumstances.
We
argue
here
that
I-R
injury
also
underpins
elements
pathology
chronic,
inflammatory
diseases,
including
rheumatoid
arthritis,
ME/CFS
and,
our
chief
focus
and
most
proximally,
Long
COVID.
Ischaemia
may
be
fibrin
amyloid
microclot
blockage
capillaries,
for
instance
as
exercise
started;
reperfusion
necessary
corollary
when
it
finishes.
rehearse
mechanistic
evidence
these
occurrences
here,
terms
their
manifestation
oxidative
stress,
hyperinflammation,
mast
cell
activation,
production
marker
metabolites
related
activities.
Such
microclot-based
phenomena
can
explain
both
breathlessness/fatigue
post-exertional
malaise
observed
conditions,
many
other
observables.
The
recognition
processes
implies,
mechanistically,
therapeutic
benefit
potentially
to
had
from
antioxidants,
anti-inflammatories,
iron
chelators,
suitable,
safe
fibrinolytics,
and/or
anti-clotting
agents.
review
considerable
existing
consistent
with
this,
biochemical
mechanisms
involved.